ADI Commitment |
Indicator |
Source |
|
Governance |
Keep universal access to immunization at the forefront of efforts to reduce child mortality, morbidity and disability, and in doing so help countries achieve their long-term health, economic and development goals. | Is the NITAG fully functional? | WHO/UNICEF Joint Reporting Form on Immunization (JRF) |
| Has the country established a NITAG? | WHO/UNICEF Joint Reporting Form on Immunization (JRF) | ||
Domestic Funding |
Increase and sustain domestic investments and funding allocations to meet the cost of traditional vaccines, fulfill new vaccine financing requirements, and provide financial support for operational implementation of immunization activities. | Government domestic funding for health as % of GDP | WHO/UNICEF Joint Reporting Form on Immunization (JRF) |
| Government funding as % of total immunization funding | African Union Africa Scorecard on Domestic Financing for Health, 2018 | ||
Equity |
Address the persistent barriers in vaccine and healthcare delivery systems, especially in the poorest, most vulnerable and most marginalized communities. | Has the country reported district-level stock-out of the DTP or MCV vaccine? | WHO/UNICEF Joint Reporting Form on Immunization (JRF) |
| Does the country conduct vaccine impact assessments for at least one newly-introduced vaccine? | Countries' reports to WHO | ||
| Proportion of districts with 80% or more MCV1 coverage | WHO/UNICEF Joint Reporting Form on Immunization (JRF) | ||
| Proportion of districts with 80% or more DTP3 coverage | WHO/UNICEF Joint Reporting Form on Immunization (JRF) | ||
Effectiveness & Efficiency |
Increase the effectiveness and efficiency of immunization delivery systems as an integrated part of strong and sustainable primary health care systems. | Has the country sustained DTP3 coverage of 90% or more for at least 3 years? (2017-2019) | WHO/UNICEF Joint Estimates of National Immunization Coverage (WUENIC) |
| Has the country sustained MCV1 coverage of 90% or more for at least 3 years? (2017-2019) | WHO/UNICEF Joint Estimates of National Immunization Coverage (WUENIC) | ||
| Has the country sustained DTP3 coverage of 90% or more for at least 3 years (2018-2020)? | WHO/UNICEF Joint Estimates of National Immunization Coverage (WUENIC) | ||
| Has the country sustained MCV1 coverage of 90% or more for at least 3 years (2018-2020)? | WHO/UNICEF Joint Estimates of National Immunization Coverage (WUENIC) | ||
Surveillance |
Attain and maintain high-quality surveillance for targeted vaccine-preventable diseases (VPDs). | Non-measles febrile rash illness rate | Countries' reports to WHO |
| NP-AFP rate | Countries' reports to WHO | ||
Coverage & VPD Elimination
|
Monitor progress towards achieving the goals of global and regional immunization plans. | DTP1 coverage | WHO/UNICEF Joint Estimates of National Immunization Coverage (WUENIC) |
| DTP3 coverage | WHO/UNICEF Joint Estimates of National Immunization Coverage (WUENIC) | ||
| MCV1 coverage | WHO/UNICEF Joint Estimates of National Immunization Coverage (WUENIC) | ||
| MCV2 coverage | WHO/UNICEF Joint Estimates of National Immunization Coverage (WUENIC) | ||
| OPV3 coverage | WHO/UNICEF Joint Estimates of National Immunization Coverage (WUENIC) | ||
| IPV1 coverage | WHO/UNICEF Joint Estimates of National Immunization Coverage (WUENIC) | ||
| Has the country introduced HPV vaccine? | Countries' reports to WHO | ||
| Has the country introduced the Hepatitis B birth dose? | Countries' reports to WHO | ||
| Has the country eliminated MNT? | Countries' reports to WHO | ||
| Has the country eliminated Measles? | Countries' reports to WHO | ||
|
Ensure polio legacy transition plans are in place by end-2016. | Polio transition plan submitted? | Countries' reports to WHO |
| Did the country have any cases of WPV or cVDPV from 2015-2018? | Countries' reports to WHO | ||
| Did the country have any cases of WPV or cVDPV in 2019? | Countries' reports to WHO | ||
| Did the country have any cases of WPV or cVDPV in 2020? | Countries' reports to WHO | ||
| cVDPV cases | Countries' reports to WHO | ||
Immunization research |
Develop a capacitated African research sector to enhance immunization implementation and uptake. | Does the country have immunization research activities within the current cMYP? (2020) | WHO/UNICEF Joint Reporting Form on Immunization (JRF) |
| Does the country currently have a comprehensive Multi-Year Plan (cMYP) for immunization? (2020) | Countries' cMYPs | ||
Advocacy and political will |
Build broad political will for the right of every child and every community to have universal access to life-saving vaccines, and by extension the best possible chance for a healthy future. | Did the country observe African Vaccination Week or World Immunization Week? | WHO survey |
Vaccine development and production |
Promote and invest in regional capacity for the development and production of vaccines in line with the African Union Pharmaceutical Manufacturing Plan including the strengthening of national regulatory authorities. | Does the country currently manufacture vaccines? | WHO/AVAREF |
| Has the country committeed to manufacture vaccines in the next 5 years? | WHO/AVAREF | ||
| Does the country have a national strategey or plan to manufacture vaccines? | WHO/AVAREF | ||
| Has the country committed to vaccine manufaturing at the highest level? | WHO/AVAREF | ||
| Has the country established (and/or is working to establish) a tech transfer hub? | WHO/AVAREF | ||
| Has the country set aside funding specifically for local manufacture of vaccines? | WHO/AVAREF | ||
| Does the country have regulatory capacity at level 3 or higher, sufficient to oversee vaccine manufacturing? | WHO/AVAREF |
Note: all data on the dashboard is updated up to end-2020. Please submit corrections by contacting us.